Azienda Socio Sanitaria Territoriale di Bergamo Ovest
- Research works
- 83 ▲ 118% vs 2013–17
- Citations
- 2.1k 24.9 per fractional work
- Top-10% rate
- 26.6% record average 16.5%
- Open access
- 43% world 28%
Not ranked overall: Azienda Socio Sanitaria Territoriale di Bergamo Ovest is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
What does Azienda Socio Sanitaria Territoriale di Bergamo Ovest specialise in?
Where its research is concentrated relative to its size: Medicine takes 4.2× the share of its output that it takes of world research.
- MedicineField · 24.8 works4.2×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Medicine, 4.2×. Every wedge is a field page.
- Medicine 4.2×
- Biochemistry, Genetics and Molecular Biology 1.8×
- Nursing 1.5×
- Immunology and Microbiology 1.3×
- Neuroscience 1.0×
- Health Professions 0.6×
- Decision Sciences 0.4×
- Dentistry 0.3×
- Psychology 0.3×
- Physics and Astronomy 0.3×
- Environmental Science 0.1×
- Social Sciences 0.0×
- Agricultural and Biological Sciences 0.0×
- Engineering 0.0×
- Computer Science 0.0×
Which keywords describe research at Azienda Socio Sanitaria Territoriale di Bergamo Ovest?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Chemotherapy, Clinical Practice Guidelines, Immunotherapy, Neoadjuvant Therapy, Clinical Trials, Radiotherapy, Epidemiology and Survival Analysis.
- Tumor Markers
- Precision Medicine
- Oxidative Stress
- Immune Checkpoint Blockade
- Treatment Response
- Prognostic Markers
- Cetuximab
- Treatment
- Metastatic Breast Cancer
- Genomic Profiling
- Gene Expression
- Prostate Cancer
- Quality of Life
- Molecular Characterization
- Biomarkers
- Survival Analysis
- Neoadjuvant Therapy
- Clinical Trials
- Epidemiology
- Chemotherapy
- Clinical Practice Guidelines
- Immunotherapy
- Radiotherapy
- Cancer
- Breast Cancer
- Molecular Subtypes
- Tumor Microenvironment
- Clinical Guidelines
- Genetic Mutations
- Prognostic Factors
- Targeted Therapy
- Breast Tumours
- Metastatic
- Screening
- Hormone Therapy
- Mortality
- PD-1 and PD-L1
- Survival
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 38 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 38 words, with their numbers
- Chemotherapy5▲ 22×14 topics
- Epidemiology4▲ 2.9×25 topics
- Clinical Practice Guidelines3▲ 18×8 topics
- Clinical Trials3▲ 13×8 topics
- Immunotherapy3▲ 12×8 topics
- Neoadjuvant Therapy3▲ 38×5 topics
- Radiotherapy3▲ 23×8 topics
- Survival Analysis2▲ 24×5 topics
- Cancer2▲ 4.6×10 topics
- Biomarkers2▲ 8.6×7 topics
- Breast Cancer2▲ 25×7 topics
- Molecular Characterization2▲ 33×4 topics
- Molecular Subtypes2▲ 71×3 topics
- Quality of Life2▲ 4.0×10 topics
- Tumor Microenvironment2▲ 14×4 topics
- Prostate Cancer2▲ 43×3 topics
- Clinical Guidelines2▲ 18×4 topics
- Gene Expression2▲ 8.3×3 topics
- Genetic Mutations2▲ 11×4 topics
- Genomic Profiling2▲ 49×2 topics
- Prognostic Factors2▲ 11×5 topics
- Metastatic Breast Cancer1▲ 75×2 topics
- Targeted Therapy1▲ 19×3 topics
- Treatment1▲ 3.5×9 topics
- Breast Tumours1▲ 84×1 topic
- Cetuximab1▲ 47×2 topics
- Metastatic1▲ 63×2 topics
- Prognostic Markers1▲ 39×2 topics
- Screening1▲ 43×2 topics
- Treatment Response1▲ 84×1 topic
- Hormone Therapy1▲ 43×2 topics
- Immune Checkpoint Blockade1▲ 34×1 topic
- Mortality1▲ 6.3×3 topics
- Oxidative Stress1▲ 2.3×8 topics
- PD-1 and PD-L11▲ 34×1 topic
- Precision Medicine1▲ 7.7×6 topics
- Survival1▲ 28×4 topics
- Tumor Markers1▲ 43×2 topics
Which research topics does Azienda Socio Sanitaria Territoriale di Bergamo Ovest publish most on?
By volume in 2022–2025: Breast Cancer Treatment Studies, Cancer Immunotherapy and Biomarkers, Prostate Cancer Treatment and Research and Prostate Cancer Diagnosis and Treatment.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Breast Cancer Treatment Studies Cancer Research 1 works
- 2 Cancer Immunotherapy and Biomarkers Oncology 1 works
- 3 Prostate Cancer Treatment and Research Pulmonary and Respiratory Medicine 1 works
- 4 Prostate Cancer Diagnosis and Treatment Pulmonary and Respiratory Medicine 1 works
- 5 HER2/EGFR in Cancer Research Oncology 1 works
- 6 Advanced Breast Cancer Therapies Pulmonary and Respiratory Medicine 1 works
- 7 Lung Cancer Research Studies Oncology 1 works
- 8 Cancer Treatment and Pharmacology Oncology 1 works
- 9 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 1 works
- 10 Head and Neck Cancer Studies Otorhinolaryngology 1 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Azienda Socio Sanitaria Territoriale di Bergamo Ovest's research output changed?
Output in 2018–2022 was 118% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.